Wednesday, 18 Jul 2018

RA/Inflammatory arthritis

Datesort ascending Type Title Save
10 Feb 2018 Social Dr Mark Genovese #RWCS - Jak inhibitor upadacitinib works well at 15 or 30mg regardless of what past therapies failed, data from RA patients. https://t.co/qKaAXOB9y0
10 Feb 2018 Social Dr Mark Genovese #RWCS - but only 10-30% DAS revision when used in RA patients who failed a TNF inhibitor https://t.co/8aJl6kz9H1
10 Feb 2018 Social Dr Mark Genovese #RWCS - biologics yield 50% DAS revision when used in MTX naive RA patients. https://t.co/wiAztTpWgw
09 Feb 2018 Social RT @alvinwellsmd: 911! Dr. Leslie Bilello, an ER Doctor, discusses Rheumatologic emergencies at RWCS 2018 https://t.co/ClsyogFAME
06 Feb 2018 News Abatacept Shows Promise for RA-ILD
04 Feb 2018 Social RT @LCalabreseDO: new onset inflammatory arthritis from CHECKPOINT Rx of cancer may be more common than new onset RA!! Immunotherapy-Induce…
03 Feb 2018 Social The RheumNow Week in Review is up!. Listen on on iTunes or here https://t.co/v6bs1aE7qe or watch it here https://t.co/k969PFZlUs. Cush reviews rising numbers, the woman behind allopurinol, vaccination, narcotics & NSAIDs and ILD
31 Jan 2018 Social New autoinflammatory Dz joins CAPS w/ Cryopyrin point mutation of NLRP3 gene as the cause for keratoendotheliitis fugax hereditaria, only seen in Finland, manifests as episodic few days of eye irritation, beginning in kids/teens and cont thru middle age https://t.co/RQKN9cKRnH
31 Jan 2018 Social February 2nd is RHEUMATOID ARTHRITIS AWARENESS DAY - Please Tweet your best advice or good news for those with #RA or send me a message! Good news for big hope and major improvements!
30 Jan 2018 Social Checkout Dr. Rachel Tate's #ACR17 video on the progress of the ACR RA RISE registry. https://t.co/2cTpDLUIq6
30 Jan 2018 Social In RA women, menopause has a greater effect on the rate of functional decline (by HAQ) and is associated with a worsening of the disease. https://t.co/R4wZIdVw3s
29 Jan 2018 Social Good news is that new data shows the survival in #RA patients to be significantly better with the use of newer and more aggressive therapies in the last 15 years!
29 Jan 2018 Social French registry shows 1278 RA pts initially received full dose RTX (1000 x2) & 14.5% went on to get reduced dose (eg, 500 x2) RTX. Both groups stayed on RTX >5 yrs (~55%), & lower dose grp had 50% fewer serious infx, less total RTX (1.4 vs 2.3 g/year) https://t.co/LOOaaDYbW7
28 Jan 2018 Social February 2nd (Saturday) is RHEUMATOID ARTHRITIS AWARENESS DAY - Please Tweet your best advice or good news for those with #RA or send me a message! Despite some challenges theres good reasons for big hope and major improvements!
27 Jan 2018 Social Among 570 RA & SpA pts with secondary loss of efficacy to TNFi - No anti-drug antibodies were 27% of Infliximab and 29% of adalimumab had antidrug Abs (none w/ ETN); 81% of these had no detectable serum drug levels. https://t.co/j5T1BkvI40
25 Jan 2018 Social ADJUVITE Study: 31 JIA pts with chronic uveitis, 4+ yrs of ocular inflammation, studied and there were significantly more responders to adalimumab 9/16 than placebo 3/15. https://t.co/ov87xcqeD9
24 Jan 2018 Social Metanalysis of 6 studies 9,045 PM/DM pts shows inflammatory myositis associated with increased risk of Venous Thromboembolic events (OR =4.31) & risk of DVT (OR =4.85) or PE (OR =4.74) https://t.co/vwiJv1FG2K
19 Jan 2018 News Weight Loss Linked to RA Improvement
18 Jan 2018 Social RT @jeffsparks: Our latest paper is out showing that weight loss is associated with improved #rheumatoidarthritis disease activity in real-…
17 Jan 2018 News IL-1 and IL-6 Inhibition Preferred in Systemic JIA